{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T08:10:00Z","timestamp":1794039000276,"version":"4.8.0"},"reference-count":82,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T00:00:00Z","timestamp":1678060800000},"content-version":"unspecified","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Division of Medicine, Royal Darwin Hospital, Darwin, NT, Australia","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2023,2,17]]},"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Aboriginal Australians are reported to have a high burden of chronic airway diseases. However, prescribing patterns and related outcomes of airway directed inhaled pharmacotherapy, (short-acting beta agonists (SABA), short-acting muscarinic antagonists (SAMA), long-acting \u03b2-agonists (LABA), long-acting muscarinic antagonists (LAMA) and inhaled corticosteroids (ICS)) among Aboriginal Australian patients with chronic airway disease have been sparsely reported in the past.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A retrospective cohort study was conducted, using clinical, spirometry data, chest radiology, primary healthcare (PHC) presentations and hospital admission rates among Aboriginal patients identified to have been prescribed inhaled pharmacotherapy in remote and rural communities referred to the respiratory specialist service in the Top End, Northern Territory of Australia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of the 372 identified active patients, 346 (93%) had inhaled pharmacotherapy prescribed (64% female, median age 57.7 years). ICS was the most common prescription (72% of the total cohort) and was recorded to be prescribed in 76% of patients with bronchiectasis, and 80% of patients with asthma or chronic obstructive pulmonary disease (COPD). Fifty-eight percent of patients had a respiratory hospital admission and 57% had a recorded PHC presentation for a respiratory issue during the study period, with a higher rate of hospital admissions among patients prescribed ICS compared with those on SAMA\/SABA or LAMA\/LABA without ICS (median rate (per person per year) 0.42 vs 0.21 and 0.21 (p=0.004). Regression models demonstrated that presence of COPD or bronchiectasis alongside ICS was associated with significantly increased hospitalisation rates (1.01 admissions\/person\/year (95%\u2009CI 0.15 to 1.87) and 0.71 admissions\/person\/year (95%\u2009CI 0.23 to 1.18) against patients without COPD\/bronchiectasis, respectively).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This study demonstrates that among Aboriginal patients with chronic airway diseases, ICS is the most common inhaled pharmacotherapy prescribed. Although LAMA\/LABA and concurrent ICS use may be appropriate among patients with asthma and COPD, the use of ICS may have detrimental effects among those with underlying bronchiectasis either in isolation or concurrent COPD and bronchiectasis, potentially leading to higher hospital admission rates.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjresp-2022-001508","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T05:40:51Z","timestamp":1678945251000},"page":"e001508","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Exploring the appropriateness of prescribing practice of inhaled pharmacotherapy among Aboriginal Australians in the Top End Northern Territory of Australia: a retrospective cohort study"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0788-7137","authenticated-orcid":false,"given":"Subash","family":"Heraganahally","sequence":"first","affiliation":[{"name":"Department of Respiratory and Sleep Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia"},{"name":"Darwin Respiratory and Sleep Health, Darwin Private Hospital, Darwin, Northern Territory, Australia"},{"name":"College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3028-0376","authenticated-orcid":false,"given":"Timothy P","family":"Howarth","sequence":"additional","affiliation":[{"name":"Darwin Respiratory and Sleep Health, Darwin Private Hospital, Darwin, Northern Territory, Australia"},{"name":"College of Health and Human Sciences, Charles Darwin University, Darwin, Northern Territory, Australia"},{"name":"Department of Technical Physics, University of Eastern Finland, Kuopio, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siji","family":"Issac","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Sleep Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angus","family":"Lloyd","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Sleep Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiidheshwar J","family":"Ravichandran","sequence":"additional","affiliation":[{"name":"Division of Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asanga","family":"Abeyaratne","sequence":"additional","affiliation":[{"name":"Menzies School of Health Research, Darwin, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavini","family":"Patel","sequence":"additional","affiliation":[{"name":"Medicines Management and Clinical Innovation and Research, Department of Health, Darwin, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,3,6]]},"reference":[{"key":"2025083110583717000_10.1.e001508.1","unstructured":"Australian Institute of Health and Welfare (AIHW) . Aboriginal and torres strait islander health performance framework 2017 report: northern territory. 2022. Available: https:\/\/www.aihw.gov.au"},{"key":"2025083110583717000_10.1.e001508.2","unstructured":"Australian Bureau of Statistics . Northern territory: aboriginal and torres strait islander population summary. 2022. Available: https:\/\/www.abs.gov.au\/articles\/northern-territory-aboriginal-and-torres-strait-islander-population-summary"},{"key":"2025083110583717000_10.1.e001508.3","unstructured":"Australian Institute of Health Welfare . Profile of indigenous australians. 2021. Available: https:\/\/www.aihw.gov.au\/reports\/australias-welfare\/profile-of-indigenous-australians"},{"key":"2025083110583717000_10.1.e001508.4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/ajr.12349","article-title":"Chronic respiratory disease in the regional and remote population of the Northern Territory top end: a perspective from the specialist respiratory outreach service","volume":"25","author":"Kruavit","year":"2017","journal-title":"Aust J Rural Health"},{"key":"2025083110583717000_10.1.e001508.5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/1754-9485.13295","article-title":"Chest computed tomography findings among adult Indigenous Australians in the Northern Territory of Australia","volume":"66","author":"Heraganahally","year":"2022","journal-title":"J Med Imaging Radiat Oncol"},{"key":"2025083110583717000_10.1.e001508.6","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.2147\/COPD.S213947","article-title":"Chronic obstructive pulmonary disease in Aboriginal patients of the Northern Territory of Australia: a landscape perspective","volume":"14","author":"Heraganahally","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025083110583717000_10.1.e001508.7","article-title":"Bronchiectasis among Australian Aboriginal and non-Aboriginal patients in the regional and remote population of the Northern Territory of Australia","volume":"21","author":"Mehra","year":"2021","journal-title":"Rural Remote Health"},{"key":"2025083110583717000_10.1.e001508.8","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1111\/imj.14718","article-title":"2004 chronic obstructive pulmonary disease with and without bronchiectasis in aboriginal australians: a comparative study","volume":"50","author":"Heraganahally","year":"2020","journal-title":"Intern Med J"},{"key":"2025083110583717000_10.1.e001508.9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/imj.14112","article-title":"Prevalence and nature of lung function abnormalities among indigenous australians referred to specialist respiratory outreach clinics in the northern territory","volume":"49","author":"Schubert","year":"2019","journal-title":"Intern Med J"},{"key":"2025083110583717000_10.1.e001508.10","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1080\/17476348.2021.1928496","article-title":"Critical analysis of Spirometric patterns in correlation to chest computed tomography among adult Indigenous Australians with chronic airway diseases","volume":"15","author":"Heraganahally","year":"2021","journal-title":"Expert Rev Respir Med"},{"key":"2025083110583717000_10.1.e001508.11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248900","article-title":"Comparison of diffusing capacity of carbon monoxide (DLCO) and total lung capacity (TLC) between Indigenous Australians and Australian Caucasian adults","volume":"16","author":"Howarth","year":"2021","journal-title":"PLoS ONE"},{"key":"2025083110583717000_10.1.e001508.12","doi-asserted-by":"crossref","unstructured":"Heraganahally SS , Howarth T , Sorger L , et al . n.d. Sex differences in pulmonary function parameters among Indigenous Australians with and without chronic airway disease. PLoS ONE;17:e0263744. doi:10.1371\/journal.pone.0263744","DOI":"10.1371\/journal.pone.0263744"},{"key":"2025083110583717000_10.1.e001508.13","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/ajr.12782","article-title":"Utility and outcomes among Indigenous and non-Indigenous patients requiring domiciliary oxygen therapy in the regional and rural Australian population","volume":"29","author":"Heraganahally","year":"2021","journal-title":"Aust J Rural Health"},{"key":"2025083110583717000_10.1.e001508.14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12873-022-00570-3","article-title":"Comparison and outcomes of emergency department presentations with respiratory disorders among Australian Indigenous and non-Indigenous patients","volume":"22","author":"Heraganahally","year":"2022","journal-title":"BMC Emerg Med"},{"key":"2025083110583717000_10.1.e001508.15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.18773\/austprescr.2017.003","article-title":"Drugs for chronic obstructive pulmonary disease","volume":"40","author":"Jenkins","year":"2017","journal-title":"Aust Prescr"},{"key":"2025083110583717000_10.1.e001508.16","unstructured":"Global Initiative for Asthma . Global strategy for asthma management and prevention. 2021. Available: www.ginasthma.org"},{"key":"2025083110583717000_10.1.e001508.17","unstructured":"Global initiative for chronic obstructive lung disease . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2021. Available: http:\/\/www.goldcopd.org"},{"key":"2025083110583717000_10.1.e001508.18","unstructured":"Yang IA , George J , Jenkins S , et al . The COPD-X plan: australian and new zealand guidelines for the management of chronic obstructive pulmonary disease 2021.COPD guidelines committee \u2013 version 2. 63 (2021). 2022. Available: https:\/\/copdx.org.au"},{"key":"2025083110583717000_10.1.e001508.19","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/resp.13934","article-title":"Concise guidance for COPD","volume":"25","author":"Dabscheck","year":"2020","journal-title":"Respirology"},{"key":"2025083110583717000_10.1.e001508.20","first-page":"100","article-title":"Copd-diagnosis, management and the role of the GP","volume":"39","author":"Walters","year":"2010","journal-title":"Aust Fam Physician"},{"key":"2025083110583717000_10.1.e001508.21","first-page":"413","article-title":"Assessment and management of asthma and chronic obstructive pulmonary disease in australian general practice","volume":"46","author":"Reddel","year":"2017","journal-title":"Aust Fam Physician"},{"key":"2025083110583717000_10.1.e001508.22","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-055635","article-title":"Effects of turnover and stability of health staff on quality of care in remote communities of the northern territory, australia: a retrospective cohort study","volume":"11","author":"Jones","year":"2021","journal-title":"BMJ Open"},{"key":"2025083110583717000_10.1.e001508.23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5694\/mja15.00937","article-title":"Therapeutic drug safety for indigenous australians: how do we close the gap?","volume":"204","author":"Thynne","year":"2016","journal-title":"Medical Journal of Australia"},{"key":"2025083110583717000_10.1.e001508.24","unstructured":"Department of Health, Northern Territory Government . The 2017-18 annual report for the department of health and the health services. 2018. Available: www.health.nt.gov.au"},{"key":"2025083110583717000_10.1.e001508.25","unstructured":"National Health Medical Research Council . Ethical conduct in research with aboriginal and torres strait islander peoples and communities: guidelines for researchers and stakeholders. Canberra Commonwealth of Australia; 2018. Available: https:\/\/www.nhmrc.gov.au"},{"key":"2025083110583717000_10.1.e001508.26","first-page":"359","article-title":"A stepwise approach to the interpretation of pulmonary function tests","volume":"89","author":"Johnson","year":"2014","journal-title":"Am Fam Physician"},{"key":"2025083110583717000_10.1.e001508.27","doi-asserted-by":"publisher","DOI":"10.4046\/trd.2017.80.2.105"},{"key":"2025083110583717000_10.1.e001508.28","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01499-2021","article-title":"ERS\/ATS technical standard on interpretive strategies for routine lung function tests","volume":"60","author":"Stanojevic","year":"2022","journal-title":"Eur Respir J"},{"key":"2025083110583717000_10.1.e001508.29","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/RTI.0b013e3181b32676","article-title":"Chronic obstructive pulmonary disease: radiology-pathology correlation","volume":"24","author":"Pipavath","year":"2009","journal-title":"J Thorac Imaging"},{"key":"2025083110583717000_10.1.e001508.30","doi-asserted-by":"crossref","unstructured":"Gaillard F , Weerakkody Y . Bronchiectasis. reference article, radiopaedia. 2022. Available: https:\/\/doi.org\/10.53347\/rID-1021","DOI":"10.53347\/rID-1021"},{"key":"2025083110583717000_10.1.e001508.31","first-page":"355","article-title":"Prevalence of asthma and chronic obstructive pulmonary disease in Aboriginal and non-Aboriginal populations: a systematic review and meta-analysis of epidemiological studies","volume":"19","author":"Ospina","year":"2012","journal-title":"Can Respir J"},{"key":"2025083110583717000_10.1.e001508.32","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.2147\/COPD.S138304","article-title":"Prevalence and associated factors of COPD among Aboriginal peoples in Canada: a cross-sectional study","volume":"12","author":"Bird","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025083110583717000_10.1.e001508.33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123204","article-title":"Incidence and prevalence of chronic obstructive pulmonary disease among Aboriginal peoples in Alberta, Canada","volume":"10","author":"Ospina","year":"2015","journal-title":"PLoS ONE"},{"key":"2025083110583717000_10.1.e001508.34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/4657420","article-title":"Prevalence and risk factors of ACO (asthma-COPD overlap) in Aboriginal people","volume":"2018","author":"Koleade","year":"2018","journal-title":"Journal of Environmental and Public Health"},{"key":"2025083110583717000_10.1.e001508.35","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/resp.13280","article-title":"Bronchiectasis in Indigenous and non-Indigenous residents of Australia and New Zealand","volume":"23","author":"Blackall","year":"2018","journal-title":"Respirology"},{"key":"2025083110583717000_10.1.e001508.36","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/imj.13739","article-title":"Ethnicity, socioeconomic status and the severity and course of non-cystic fibrosis bronchiectasis","volume":"48","author":"de Boer","year":"2018","journal-title":"Intern Med J"},{"key":"2025083110583717000_10.1.e001508.37","doi-asserted-by":"crossref","unstructured":"Kew KM , Mavergames C , Walters JAE . Long-Acting beta2-agonists for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2013:CD010177. doi:10.1002\/14651858.CD010177.pub2","DOI":"10.1002\/14651858.CD010177.pub2"},{"key":"2025083110583717000_10.1.e001508.38","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12890-020-1152-8","article-title":"Treatment with LABA versus Lama for stable COPD: a systematic review and meta-analysis","volume":"20","author":"Koarai","year":"2020","journal-title":"BMC Pulm Med"},{"key":"2025083110583717000_10.1.e001508.39","article-title":"Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta-analysis","volume":"12","author":"Oba","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2025083110583717000_10.1.e001508.40","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01219-2018"},{"key":"2025083110583717000_10.1.e001508.41","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1038\/d41586-020-01376-8","article-title":"Should physicians still be prescribing steroid inhalers as a first-line treatment for COPD?","volume":"581","author":"Photopoulos","year":"2020","journal-title":"Nature"},{"key":"2025083110583717000_10.1.e001508.42","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/CPM.0000000000000382","article-title":"Excessive dynamic airway collapse: a COPD\/asthma mimic or a treatment-emergent consequence of inhaled corticosteroid therapy: case series and brief literature review","volume":"27","author":"Heraganahally","year":"2020","journal-title":"Clin Pulm Med"},{"key":"2025083110583717000_10.1.e001508.43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5694\/mja16.00226","article-title":"Spirometry reference values in Indigenous Australians: a systematic review","volume":"205","author":"Blake","year":"2016","journal-title":"Med J Aust"},{"key":"2025083110583717000_10.1.e001508.44","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/17476348.2021.1847649","article-title":"Lung function parameters among Australian Aboriginal \u201c apparently healthy \u201d adults: an Australian Caucasian and global lung function initiative (GLI-2012) various ethnic norms comparative study","volume":"15","author":"Heraganahally","year":"2021","journal-title":"Expert Rev Respir Med"},{"key":"2025083110583717000_10.1.e001508.45","unstructured":"White E , James A , de Klerk N , et al . Selection of appropriate spirometry reference values in aboriginal australians. Australian Indigenous Health Bulletin 2019;19."},{"key":"2025083110583717000_10.1.e001508.46","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2021-001135","article-title":"Implications of using the GLI-2012, gold and Australian COPD-X recommendations in assessing the severity of airflow limitation on spirometry among an Indigenous population with COPD: an Indigenous Australians perspective study","volume":"8","author":"Heraganahally","year":"2021","journal-title":"BMJ Open Respir Res"},{"key":"2025083110583717000_10.1.e001508.47","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.2147\/COPD.S328137","article-title":"The effects of inhaled airway directed pharmacotherapy on decline in lung function parameters among Indigenous Australian adults with and without underlying airway disease","volume":"16","author":"Heraganahally","year":"2021","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025083110583717000_10.1.e001508.48","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00629-2017","article-title":"European respiratory Society guidelines for the management of adult bronchiectasis","volume":"50","author":"Polverino","year":"2017","journal-title":"Eur Respir J"},{"key":"2025083110583717000_10.1.e001508.49","article-title":"Inhaled corticosteroids for bronchiectasis","volume":"5","author":"Kapur","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2025083110583717000_10.1.e001508.50","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-212463"},{"key":"2025083110583717000_10.1.e001508.51","unstructured":"Remote Primary Health Care Manuals . CARPA standard treatment manual. 7th edition. Alice Springs, NT: Centre for Remote Health, 2017."},{"key":"2025083110583717000_10.1.e001508.52","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4103\/1817-1737.172297","article-title":"Bacterial colonization and associated factors in patients with bronchiectasis","volume":"11","author":"Borekci","year":"2016","journal-title":"Ann Thorac Med"},{"key":"2025083110583717000_10.1.e001508.53","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/resp.13633","article-title":"Management of COPD in asia: A position statement of the asian pacific society of respirology","volume":"24","author":"Rhee","year":"2019","journal-title":"Respirology"},{"key":"2025083110583717000_10.1.e001508.54","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00408-019-00280-x","article-title":"Management of Australian adults with bronchiectasis in tertiary care: evidence-based or access-driven?","volume":"197","author":"Visser","year":"2019","journal-title":"Lung"},{"key":"2025083110583717000_10.1.e001508.55","unstructured":"AIHW . Respiratory medication use in australia 2003\u20132013: treatment of asthma and COPD. cat. no: ACM 31:85. 2015. Available: https:\/\/www.aihw.gov.au \u203a reports \u203a respiratory-medica"},{"key":"2025083110583717000_10.1.e001508.56","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.2147\/COPD.S332151","article-title":"Comparison of risk of pneumonia caused by fluticasone propionate versus budesonide in chronic obstructive pulmonary disease: a nationwide retrospective cohort study","volume":"16","author":"Choi","year":"2021","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025083110583717000_10.1.e001508.57","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S143656"},{"key":"2025083110583717000_10.1.e001508.58","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01896-2018","article-title":"Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis","volume":"54","author":"Henkle","year":"2019","journal-title":"Eur Respir J"},{"key":"2025083110583717000_10.1.e001508.59","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.2147\/COPD.S311236","article-title":"Inhaled corticosteroid therapy in bronchiectasis is associated with all-cause mortality: a prospective cohort study","volume":"16","author":"H\u00e5kansson","year":"2021","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025083110583717000_10.1.e001508.60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/22423982.2021.1946324","article-title":"Acute health care among Indigenous patients in Canada: a scoping review","volume":"80","author":"Vigneault","year":"2021","journal-title":"International Journal of Circumpolar Health"},{"key":"2025083110583717000_10.1.e001508.61","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2011.02444.x"},{"key":"2025083110583717000_10.1.e001508.62","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1353\/hpu.2017.0114","article-title":"Assessing health care access and use among Indigenous peoples in Alberta: a systematic review","volume":"28","author":"Nader","year":"2017","journal-title":"J Health Care Poor Underserved"},{"key":"2025083110583717000_10.1.e001508.63","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.2147\/COPD.S154097","article-title":"Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study","volume":"13","author":"Casas","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025083110583717000_10.1.e001508.64","doi-asserted-by":"crossref","first-page":"458","DOI":"10.5588\/ijtld.16.0633","article-title":"Respiratory medication use in primary care among COPD subjects in four Latin American countries","volume":"21","author":"Jardim","year":"2017","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025083110583717000_10.1.e001508.65","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmn006"},{"key":"2025083110583717000_10.1.e001508.66","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.2147\/COPD.S210897","article-title":"Trends in prescriptions and costs of inhaled medications in chronic obstructive pulmonary disease: a 19-year population-based study from Canada","volume":"14","author":"Tavakoli","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025083110583717000_10.1.e001508.67","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2147\/COPD.S361839","article-title":"Differences in the spirometry parameters between Indigenous and non-Indigenous patients with COPD: a matched control study","volume":"17","author":"Sze","year":"2022","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025083110583717000_10.1.e001508.68","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/imj.15310","article-title":"Comparison of clinical manifestation among Australian Indigenous and non-Indigenous patients presenting with pleural effusion","volume":"52","author":"Heraganahally","year":"2022","journal-title":"Intern Med J"},{"key":"2025083110583717000_10.1.e001508.69","doi-asserted-by":"crossref","unstructured":"Seyedshahabedin MM , Howarth TP , Mo L , et al . Flexible bronchoscopy indications and outcomes between Indigenous and non-Indigenous patients in the Northern Territory of Australia. Intern Med J 5, 2022. doi:10.1111\/imj.15865","DOI":"10.1111\/imj.15865"},{"key":"2025083110583717000_10.1.e001508.70","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsz248","article-title":"Sleep apnoea among Australian Aboriginal and non-Aboriginal patients in the Northern Territory of australia-a comparative study","volume":"43","author":"Heraganahally","year":"2020","journal-title":"Sleep"},{"key":"2025083110583717000_10.1.e001508.71","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.sleep.2022.06.014","article-title":"Sleep quality and obstructive sleep apnoea in indigenous and non-indigenous australian children","volume":"98","author":"Howarth","year":"2022","journal-title":"Sleep Med"},{"key":"2025083110583717000_10.1.e001508.72","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2022-001295","article-title":"Copd disease knowledge, self-awareness and reasons for hospital presentations among a predominately indigenous australian cohort: a study to explore preventable hospitalisation","volume":"9","author":"Pal","year":"2022","journal-title":"BMJ Open Respir Res"},{"key":"2025083110583717000_10.1.e001508.73","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbscr.2022.100075","article-title":"Sleep disorders among Aboriginal Australians with Machado-Joseph disease: quantitative results from a multiple methods study to assess the experience of people living with the disease and their caregivers","volume":"12","author":"LaGrappe","year":"2022","journal-title":"Neurobiol Sleep Circadian Rhythms"},{"key":"2025083110583717000_10.1.e001508.74","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2147\/NSS.S258330","article-title":"Gender differences in the clinical and polysomnographic characteristics among Australian Aboriginal patients with obstructive sleep apnea","volume":"12","author":"Mehra","year":"2020","journal-title":"Nat Sci Sleep"},{"key":"2025083110583717000_10.1.e001508.75","doi-asserted-by":"crossref","unstructured":"Benn E , Wirth H , Short T , et al . n.d. The top end sleepiness scale (Tess): a new tool to assess subjective daytime sleepiness among Indigenous Australian adults. NSS;Volume 13:315\u201328. doi:10.2147\/NSS.S298409","DOI":"10.2147\/NSS.S298409"},{"key":"2025083110583717000_10.1.e001508.76","doi-asserted-by":"crossref","unstructured":"Heraganahally SS , Howarth TP , Wirth H , et al . Validity of the new \u201ctop end sleepiness scale\u201d against the STOP-bang tool in predicting obstructive sleep apnoea among indigenous australian adults. Intern Med J 20, 2021. doi:10.1111\/imj.15633","DOI":"10.1111\/imj.15633"},{"key":"2025083110583717000_10.1.e001508.77","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.2147\/NSS.S286403","article-title":"Positional sleep apnea among regional and remote australian population and simulated positional treatment effects","volume":"12","author":"Garg","year":"2020","journal-title":"Nat Sci Sleep"},{"key":"2025083110583717000_10.1.e001508.78","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.2147\/JAA.S376213","article-title":"The prevalence of bronchodilator responsiveness \u201casthma\u201d among adult indigenous australians referred for lung function testing in the top end northern territory of australia","volume":"15","author":"Heraganahally","year":"2022","journal-title":"J Asthma Allergy"},{"key":"2025083110583717000_10.1.e001508.79","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1007\/s11096-014-0030-y","article-title":"Attitudes of pharmacists to provision of home medicines review for indigenous australians","volume":"36","author":"Swain","year":"2014","journal-title":"Int J Clin Pharm"},{"key":"2025083110583717000_10.1.e001508.80","first-page":"16","article-title":"Accredited pharmacist special interest group: hmr in remote indigenous communities","volume":"36","author":"Vaughan","year":"2017","journal-title":"Australian Pharmacist"},{"key":"2025083110583717000_10.1.e001508.81","article-title":"Issues with prescribed medications in Aboriginal communities: Aboriginal health workers\u2019 perspectives","volume":"6","author":"Hamrosi","year":"2006","journal-title":"Rural Remote Health"},{"key":"2025083110583717000_10.1.e001508.82","doi-asserted-by":"crossref","DOI":"10.3390\/pharmacy9040177","article-title":"Medicines optimisation for respiratory patients: the establishment of a new consultant respiratory pharmacist role in Northern Ireland","volume":"9","author":"Gormley","year":"2021","journal-title":"Pharmacy (Basel)"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2022-001508","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T17:58:52Z","timestamp":1756663132000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2022-001508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,3,6]]},"published-print":{"date-parts":[[2023,3]]}},"alternative-id":["10.1136\/bmjresp-2022-001508"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2022-001508","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3]]}}}